Search results for "Pain relief"

showing 4 items of 24 documents

Is arthrocentesis of temporomandibular joint with corticosteroids beneficial? A systematic review

2018

Background Temporomandibular disorders (TMDs) are musculoskeletal conditions that can inhibit the normal function of temporomandibular joints (TMJs) and affect the patient’s quality of life, negatively. Arthrocentesis (AC) is a minimally invasive surgical procedure used for treating TMDs. The aim of present paper is to evaluate the advantages of administrating corticosteroid (CS) during AC by reviewing high quality released articles. Material and Methods Searching on Cochrane Library, Web of Science, Google Scholar, PubMed, ProQuest, and Scopus databases were performed with focusing on proper key words. Related titles and abstracts, up to December 2017, were screened and selected based on i…

medicine.medical_specialtyRandomizationmedicine.medical_treatmentMEDLINEPain reliefReviewCochrane Librarylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifestomatognathic systemlawmedicineHumans030212 general & internal medicineGlucocorticoidsGeneral DentistryRandomized Controlled Trials as Topicbusiness.industryArthrocentesis030206 dentistryTemporomandibular Joint Disorders:CIENCIAS MÉDICAS [UNESCO]Combined Modality TherapyTemporomandibular jointstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASPhysical therapySurgeryOral SurgerybusinessArthrocentesis
researchProduct

Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study

2013

Results 67 of the 96 female patients of the intention-to-treat population of the main study had regular menstrual cycles and were thus included in this subgroup analysis. 77 migraine attacks classified as related to menses were treated with frovatriptan and 78 with almotriptan. Rate of pain relief at 2and 4-hrs was 36% and 53% for frovatriptan and 41% and 50% for almotriptan (p=NS between treatments). Rate of pain free at 2and 4-hrs was 19% and 47% with frovatriptan and 29% and 54% for almotriptan (p=NS). At 24-hrs, 62% of frovatriptanand 67% of almotriptan-treated patients had pain relief, while 60% vs. 67% were pain free (p=NS). Recurrence at 24-hrs was significantly (p<0.05) lower with f…

medicine.medical_specialtyeducation.field_of_studyTraditional medicinebusiness.industrymedia_common.quotation_subjectPopulationPain reliefClinical NeurologySubgroup analysisGeneral Medicinemedicine.diseaseAnesthesiology and Pain MedicineMigraineInternal medicineAlmotriptanFemale patientPoster PresentationmedicineNeurology (clinical)FrovatriptaneducationbusinessMenstrual cyclemedicine.drugmedia_commonThe Journal of Headache and Pain
researchProduct

Clinical management of alveolar osteitis. A systematic review

2021

Background Alveolar Osteitis (AO) is one of the most common complications of tooth extraction. Several therapeutic interventions have been described for the treatment of AO, however, there are no treatment standardized protocols. The aim of this study was to conduct a systematic review on the efficacy in pain control of the different treatments for AO. The feasibility of the application of these interventions is also discussed. Material and Methods A structured electronic and hand search strategy was applied to PubMed, Scopus, Cochrane Library, OpenGrey, and Google Scholar between January 2010 and July 2020 to identify studies according to PRISMA guidelines. The inclusion criteria were orig…

medicine.medical_specialtyimpacted toothVisual analogue scalePsychological interventionPain reliefMEDLINEDry SocketReviewCochrane LibraryPain controlPlatelet-Rich FibrinMedicineHumansPain Managementthird molarGeneral DentistryUNESCO:CIENCIAS MÉDICASbusiness.industryantibiotic prophylaxissurgical wound infectionmedicine.diseaseClinical trialOtorhinolaryngologyTooth ExtractionPhysical therapySurgeryOsteitisOral SurgerybusinessMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

NMDA receptor antagonists and pain relief: A meta-analysis of experimental trials

2019

ObjectiveWe conducted a meta-analysis of controlled trials that used experimental models of acute pain and hyperalgesia to examine the analgesic effects of NMDA receptor (NMDAR) antagonists.MethodsSix major databases were systematically searched (to March 2018) for studies using human evoked pain models to compare NMDAR antagonists with no-intervention controls. Pain outcome data were analyzed with random-effects meta-analysis.ResultsSearches identified 70 eligible trials (n = 1,069). Meta-analysis found that low-dose ketamine (&lt;1 mg/kg) produced a decrease in hyperalgesic area (standardized mean difference 0.54, 95% confidence interval [CI] 0.34, 0.74, p &lt; 0.001) and a 1.2-point decr…

pain NMDA ketamine dextromethorphan analgesia review meta-analysisAnalgesicPain reliefDextromethorphanReceptors N-Methyl-D-Aspartate03 medical and health sciences0302 clinical medicine030202 anesthesiologymedicineHumansKetamineAcute painbusiness.industryChronic painModels Theoreticalmedicine.diseaseAcute PainHyperalgesiaAnesthesiaMeta-analysisHyperalgesiaRC0321NMDA receptorKetamineNeurology (clinical)medicine.symptombusinessExcitatory Amino Acid Antagonists030217 neurology & neurosurgerymedicine.drug
researchProduct